New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 23, 2014
10:01 EDTATHN, PLD, ILMN, GSK, ETFC, AGN, VRX, SPWR, MDSO, HAFC, FLDM, CREE, AEM, WOSYY, TMK, SANM, LL, GLF, EFX, COG, AOS, VSI, TEOn The Fly: Analyst Upgrade Summary
A.O. Smith (AOS) upgraded at BMO Capital... Agnico-Eagle (AEM) upgraded to Outperform from Sector Perform at RBC Capital... Allergan (AGN) upgraded to Overweight from Neutral at JPMorgan... Cabot Oil & Gas (COG) upgraded to Buy from Hold at Societe Generale... Cree (CREE) upgraded to Buy from Hold at Summit Research... E-Trade (ETFC) upgraded to Outperform from Market Perform at Wells Fargo... Equifax (EFX) upgraded at Credit Suisse... Fluidigm (FLDM) upgraded to Buy from Neutral at Mizuho... GlaxoSmithKline (GSK) upgraded to Buy from Hold at Argus... GulfMark Offshore (GLF) upgraded to Buy from Neutral at Global Hunter... Hanmi Financial (HAFC) upgraded to Outperform from Market Perform at Fig Partners... Illumina (ILMN) upgraded to Buy from Hold at Maxim... Lumber Liquidators (LL) upgraded to Buy from Neutral at Longbow... Medidata Solutions (MDSO) upgraded to Buy from Neutral at B. Riley... Prologis (PLD) upgraded to Buy from Neutral at ISI Group... Sanmina (SANM) upgraded to Buy from Hold at Craig-Hallum... SunPower (SPWR) upgraded to Buy from Hold at Deutsche Bank... TECO Energy (TE) upgraded to Neutral from Sell at UBS... Torchmark (TMK) assumed with a Market Perform from Underperform at Keefe Bruyette... Valeant (VRX) upgraded to Buy from Hold at TD Securities... Vitamin Shoppe (VSI) upgraded at Sterne Agee... Wolseley (WOSYY) upgraded to Outperform from Neutral at Credit Suisse... athenahealth (ATHN) upgraded to Overweight from Equal Weight at Morgan Stanley.
News For AOS;AEM;AGN;COG;CREE;ETFC;EFX;FLDM;GSK;GLF;HAFC;ILMN;LL;MDSO;PLD;SANM;SPWR;TE;TMK;VRX;VSI;WOSYY;ATHN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
January 21, 2015
07:35 EDTCREECree upgraded to Overweight from Equal Weight at Stephens
Price target is $42.
07:22 EDTAGNActavis price target raised to $330 from $280 at Deutsche Bank
Subscribe for More Information
05:50 EDTEFXFair Isaac upgraded to Overweight from Equal Weight at Barclays
Barclays upgraded Fair Isaac to Overweight citing growth at Scores, software sales momentum and the company's continued buybacks. The firm raised its price target for shares to $85 from $65. Barclays coupled the upgrade with a downgrade of Dun & Bradstreet (DNB) to Underweight. It also keeps an Overweight rating on Equifax (EFX).
05:26 EDTWOSYYWolseley upgraded to Neutral from Underperform at Exane BNP Paribas
Subscribe for More Information
January 20, 2015
18:30 EDTCREEOn The Fly: After Hours Movers
Subscribe for More Information
16:09 EDTCREECree says LED lighting market still in early stages
Cree (CREE) CEO Chuck Swoboda said in the company's earnings release, "We made solid progress in Q2 with operating margin higher than targeted due to an improvement in gross margins in our lighting business. The market for LED lighting is still in the early stages, our new product pipeline is strong, sales momentum is building and our brand is growing in the market. As evidenced by our significant share repurchases in Q2, we believe we are on the right track to continue to grow the company and increase profits over the next several years." Cree peers include SemiLEDs (LEDS) and Acuity Brands (AYI). Cree shares are up 6% in after-hours trading to $34.40 after reporting better than expected Q2 results.
16:03 EDTCREECree sees Q3 EPS 21c-25c, consensus 21c
Sees Q3 revenue $395M-$415M, consensus $404.42M. Sees Q3 non-GAAP gross margin 33.5%+/-.
16:02 EDTCREECree reports Q2 EPS 33c, consensus 22c
Reports Q2 revenue $413.2M, consensus $412.12M.
15:48 EDTCREECreeJanuary weekly 32 straddle priced for 10.5% movement into Q4
Subscribe for More Information
15:21 EDTCREENotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include IBM (IBM), consensus $5.41; Netflix (NFLX), consensus 45c; CA Technologies (CA), consensus 60c; Cree (CREE), consensus 22c; Woodward (WWD), consensus 46c; Fulton Financial (FULT), consensus 21c; Advanced Micro Devices (AMD), consensus 1c; Interactive Brokers (IBKR), consensus 6c; Pinnacle Financial (PNFP), consensus 53c.
14:58 EDTCREECree technical comments ahead of earnings
There has been a pause in the dominant downtrend that began in the fall of 2013 in recent weeks that has seen basing at the $30 area. That level is the key area to watch on the downside should news be more negative than traders appear to expect. A breakdown below the $30 level could lead to a test of the 52-week low at $27.25 that was hit during the October market lows last year. If there is a positive surprise, the stock has a great deal of work ahead to turn the trend even toward neutral on a longer-term basis. Resistance levels to watch as potential upside objectives are at $35.46 and $37.26 which is the high of the range prior to the bearish gap down from early October. It would take a move above the $40 area for the stock to be back on a more bullish price path. The shares have a history of volatile reactions around earnings events with price gaps which could exceed levels noted.
14:27 EDTCREECree January weekly 31 straddle priced for 9.9% movement into Q4
13:45 EDTILMNIllumina rises as genomics project seen being announced in State of the Union
Subscribe for More Information
11:24 EDTILMNIllumina could see headline boost from U.S. genomics project, says Wells Fargo
After biotech industry publication BioCentury said Friday that the president may announce a new genomics project to sequence up to one million human genomes as part of his State of the Union speech tonight, Wells Fargo said that it believes such an announcement could be a headline catalyst for Illumina since it would mean the U.S. needs additional sequencing capacity. However, such a project would be long-term in nature, Wells Fargo cautioned, adding that such a plan would more likely support existing Illumina growth assumptions than push those forecasts up. Shares of Illumina are up 6% to $194.85 in morning trading ahead of tonight's speech by the president.
09:45 EDTCREE, CREECree estimates lowered ahead of Q2 report, says CLSA
CLSA lowered Cree estimates ahead of Tuesday's Q2 report following checks that indicate a lack of demand improvement in China LED demand. The analyst also sees risk to increased inventory build that could lead to a cut in fab utilization and reiterates its Underperform rating.
08:46 EDTCREECree January weekly volatility elevated into Q4 and outlook
Subscribe for More Information
07:53 EDTFLDMFluidigm upgraded to Outperform at Cowen
Subscribe for More Information
06:36 EDTFLDMFluidigm upgraded to Outperform from Market Perform at Cowen
Subscribe for More Information
January 16, 2015
08:31 EDTGSKGlaxoSmithKline CEO says more IPOs like ViiV could happen, Retuers says
Subscribe for More Information
06:45 EDTETFCE-Trade volatility increases into Q4 and outlook
E-Trade January weekly call option implied volatility is at 52, February is at 46, April is at 37, July is at 35; compared to its 26-week average of 34 according to Track Data, suggesting large near term price movement into the expected release of Q4 results on January 22.
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use